Akiyama; Tetsu

Patent Applications and Registrations

Patent applications and USPTO patent grants for Akiyama; Tetsu.The latest application filed is for "refractory asthma prophylactic/therapeutic agent screening method, and refractory asthma prophylactic/therapeutic agent".

Company Profile

2.9.8

Akiyama; Tetsu - Tokyo JP
Akiyama; Tetsu - Tama JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Nucleic acid inhibiting expression of the MEX3B gene, MEX3B gene expression inhibitor, method for inhibiting MEX3B gene expression, and prophylactic or therapeutic agent for disease caused by MEX3B gene expression Grant 11,312,956 - Akiyama , et al. April 26, 2	2022-04-26
Method for screening prophylactic or therapeutic agents for diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5 and agent for the prevention or treatment of diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5 Grant 11,279,935 - Akiyama , et al. March 22, 2	2022-03-22
Refractory Asthma Prophylactic/therapeutic Agent Screening Method, And Refractory Asthma Prophylactic/therapeutic Agent App 20210163610 - AKIYAMA; TETSU ; et al.	2021-06-03
Nucleic Acid Inhibiting Expression Of The Mex3b Gene, Mex3b Gene Expression Inhibitor, Method For Inhibiting Mex3b Gene Expression, And Prophylactic Or Therapeutic Agent For Disease Caused By Mex3b Gene Expression App 20210079390 - AKIYAMA; Tetsu ; et al.	2021-03-18
Method For Screening Prophylactic Or Therapeutic Agents For Diseases Caused By Interleukin 6, Interleukin 13, Tnf, G-csf, Cxcl1, Cxcl2, Or Cxcl5 And Agent For The Prevention Or Treatment Of Diseases Caused By Interleukin 6, Interleukin 13, Tnf, G-csf, Cxcl1, Cxcl2, Or Cxcl5 App 20200325479 - AKIYAMA; TETSU ; et al.	2020-10-15
sFRP expression enhancing agent Grant 7,705,196 - Akiyama , et al. April 27, 2	2010-04-27
Anti-BAMBI antibody and diagnostic or remedy for colon cancer and liver cancer Grant 7,491,802 - Akiyama , et al. February 17, 2	2009-02-17
Sfrp Expression Enhancing Agent App 20080227695 - Akiyama; Tetsu ; et al.	2008-09-18
Apoptosis-inducing gene and utilization of the same Grant 7,422,906 - Akiyama , et al. September 9, 2	2008-09-09
.beta.-catenin nuclear localized protein Grant 7,358,348 - Akiyama , et al. April 15, 2	2008-04-15
Colon cancer metastasis inhibitor Grant 7,297,779 - Akiyama , et al. November 20, 2	2007-11-20
Transcriptional activation inhibitory protein Grant 7,250,488 - Akiyama , et al. July 31, 2	2007-07-31
Anti-bambi antibody and diagnostic or remedy for colon cancer and liver cancer App 20070065446 - Akiyama; Tetsu ; et al.	2007-03-22
Apoptosis-inducing gene and utilization of the same App 20060172930 - Akiyama; Tetsu ; et al.	2006-08-03
Colon cancer metastasis inhibitor App 20060067919 - Akiyama; Tetsu ; et al.	2006-03-30
Beta-catenin nuclear localized protein App 20040073001 - Akiyama, Tetsu ; et al.	2004-04-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.